Status:
COMPLETED
Correlation Between Preoperative NT-proBNP and Postoperative AKI
Lead Sponsor:
Xijing Hospital
Conditions:
Acute Kidney Injury
Eligibility:
All Genders
18+ years
Brief Summary
Accurate preoperative AKI risk prediction is of great significance for improving patient outcomes. The use of preoperative NT-proBNP can provide a more precise assessment of the body's fluid load stat...
Detailed Description
Acute kidney injury (AKI) refers to a rapid decrease in glomerular filtration rate. Postoperative AKI refers to AKI that occurs within 7 days after surgery and is one of the serious perioperative comp...
Eligibility Criteria
Inclusion
- ≥18 years
- undergoing elective surgery
- Have a history of NT-proBNP and creatinine testing within 7 days before surgery
Exclusion
- Patients undergoing chronic peritoneal or hemodialysis treatment; patients who have undergone kidney transplantation; preoperative serum creatinine levels\>4.5mg/dL (400 μ Mol/L) or end-stage renal disease patient (defined as glomerular filtration rate\<15ml • min-1 • 1.73m-2)
- Organ transplantation surgery
- Pregnant patients
- Surgical duration\<1 hour
Key Trial Info
Start Date :
July 10 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2024
Estimated Enrollment :
629 Patients enrolled
Trial Details
Trial ID
NCT06145347
Start Date
July 10 2023
End Date
July 1 2024
Last Update
August 16 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Xijing Hospital
Xi'an, Shaanxi, China, 710032